Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The hematopoietic stem cells transplantation (HSCT) market size is set to grow by USD 2383.61 million between 2023 and 2027, and register a...
The soft tissue repair market refers to the medical devices and treatments used to repair or replace damaged or injured soft tissues in the body, such as tendons, ligaments, muscles, and cartilage. This can include both surgical and non-surgical interventions, such as physical therapy and regenerative medicine.Soft...
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today its participation in three upcoming conferences during the... | May 8, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today its participation in three upcoming conferences during the month of May. Chris Temple, Vice President of Operations, will be par...
StockNews.com upgraded shares of Athersys (NASDAQ:ATHX – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday morning. Separately, Alliance Global Partners began coverage on shares of Athersys in a report on Monday, March 6th. They set a buy rating and a $5.50 target price on the […]